References
- Lifton RP, Dluhy RG, Powers M, et al. A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355(6357):262–265.
- Campino C, Trejo P, Carvajal CA, et al. Pregnancy normalized familial hyperaldosteronism type I: A novel role for progesterone. J Hum Hypertens. 2015;29(2):138–139.
- Hamilton E, O’Callaghan C, O’Brien RM, et al. Familial hyperaldosteronism type 1 in pregnancy. Intern Med J. 2009;29(2):138–139.
- Wyckoff JA, Seely EW, Hurwitz S, et al. Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension. 2000. 35(2):668–672.
- Mulatero P, Cella SM, Di Williams TA, et al. Glucocorticoid remediable aldosteronism: Low morbidity and mortality in a four-generation Italian pedigree. J Clin Endocrinol Metab. 2002;87(7):3187–3191.
- Rossi GP, Bisogni V. A useful tool to improve the case detection rate of primary aldosteronism: the aldosterone -renin ratio (ARR)-App. J Hypertens. 2016. 34(5):1019–1021.
- Escher G. Hyperaldosteronism in pregnancy. Ther Adv Cardiovasc Dis. 2009;3(2):123–132.
- Vecchiola A, Lagos CF, Fuentes CA, et al. Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro. Reprod Biol Endocrinol. 2013;11:76.